Case report and literature review: management of Paxlovid (nirmatrelvir/ritonavir)-induced acute tacrolimus toxicity in a patient with systemic lupus erythematosus

Despite the availability of effective vaccines and treatments for SARS-CoV-2, managing COVID-19 in patients with systemic lupus erythematosus (SLE) remains challenging, particularly considering drug-drug interactions (DDIs). Here, we present a case of DDIs between Tacrolimus (Tac) and nirmatrelvir/r...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Chenxiao Jiang, Xiaodi Yan, Peng Xia, Xuemei Luo, Haoyue Zheng, Hanwen Tong, Yun Liu, Huaijun Zhu, Peng Xu, Jun Wang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2024-06-01
Edice:	Frontiers in Pharmacology
Témata:	systemic lupus erythematosus tacrolimus nirmatrelvir/ritonavir CYP induction case report
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1364121/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!